www.fdanews.com/articles/177517-hepatiqs-phm-index-gains-expanded-clearance
Hepatiq’s PHM Index Gains Expanded Clearance
July 13, 2016
Hepatiq has earned FDA clearance to tack on two extra indices of liver disease severity to its FDA-cleared perfused hepatic mass (PHM) index, which is intended to “correlate with future adverse events,” the company announced Tuesday.
The two indices include, fSV, an index of splenic volume and portal hypertension, and fLV, an index of functional hepatic volume, according to the company. — Anisa Jibrell